Acadia Pharmaceuticals Inc. ACAD shares are trading higher by $4.20 at $33.74 in Wednesday's session.
After the close on Tuesday, the company announced a Q2 EPS beat of 17 cents along with a $10 million beat for sales.
After a much higher open, Acadia had only a 15-cent retreat to $32.60 before continuing its move higher. So far, the ensuing rally has taken the stock to $34.95, but hasn't been able to hold that elevated level. That high coincides with its May 1 high of $34.98.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in